Alzheimer’s disease neuropathological change (ADNC) is characterised by the presence of amyloid and phosphorylated tau (p-tau) in the brain, which when associated with clinical dementia is Alzheimer’s disease (AD). Here, MAPT is linked to Alzheimer's disease neuropathologic change.